Loading...

bioMérieux S.A.

BMXMFPNK
Healthcare
Medical - Diagnostics & Research
$142.45
$0.00(0.00%)

bioMérieux S.A. BMXMF Peers

See (BMXMF) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Diagnostics & Research Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
BMXMF$142.45+0.00%15.8B31.81$4.22+0.73%
LZAGY$70.32-1.46%51.3B64.00$1.11+0.59%
LZAGF$716.80+0.20%49.6B65.50$11.09+0.34%
WUXAY$10.20-0.49%28.5B18.80$0.54+3.22%
WUXIF$7.34+0.00%20.1B13.59$0.54+0.25%
ERFSF$71.01-1.02%12.9B30.43$2.40+0.97%
SKHCF$18.26+1.39%8.8B25.01$0.73+3.84%
SKHHY$17.64-1.01%8.5B23.89$0.74+3.82%
DSRLF$107.68+0.00%5.9B26.96$4.03+1.10%
HNGZY$4.00+0.00%5.3B26.67$0.15+1.03%
Showing 1 to 10 of 79 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

BMXMF vs LZAGY Comparison

BMXMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BMXMF stands at 15.8B. In comparison, LZAGY has a market cap of 51.3B. Regarding current trading prices, BMXMF is priced at $142.45, while LZAGY trades at $70.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BMXMF currently has a P/E ratio of 31.81, whereas LZAGY's P/E ratio is 64.00. In terms of profitability, BMXMF's ROE is +0.10%, compared to LZAGY's ROE of +0.06%. Regarding short-term risk, BMXMF is less volatile compared to LZAGY. This indicates potentially lower risk in terms of short-term price fluctuations for BMXMF.

Stock Price Comparison

Loading...

Frequently Asked Questions

;